KIRIN
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

KIRIN Trademark

Serial Number: 79269305 • Registration: 6350506

KIRIN is a trademark filed by Kirin Holdings Kabushiki Kaisha (also trading as Kirin Holdings Company, Limited) on April 23, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Trademark Details

Filing Date

April 23, 2019

Registration Date

May 18, 2021

Published for Opposition

March 2, 2021

Goods & Services

Milk ferments for pharmaceutical purposes; collyrium; nasal spray preparations for medical purposes; nasal spray preparations; vaginal pharmaceutical preparations for treating fungal infections; pharmaceutical antitussive-cold preparations; preparations for destroying vermin; fungicides; herbicides; pharmaceutical preparations for the treatment of gastrointestinal diseases, cancer, bacterial skin infections, vitamin deficiencies, intestinal bacteria, influenza, colds, physical disorders, fatigue, anemia, leukopenia, hyperphosphatemia, hyperparathyroidism, leukemia, influenza, HIV, myelodysplastic syndrome, hepatitis virus infection and autoimmune hepatitis; pharmaceutical preparations for mobilization of peripheral blood progenitor cells; pharmaceutical preparations for conditioning treatment prior to hematopoietic stem cell transplantation; medical and veterinary preparations, namely, diagnostic, bacterial, and bacteriological preparations for medical or veterinary purposes; vitamin preparations, not for pain relief or cosmetic purposes; vitamin substances in the nature of vitamin supplements, not for pain relief or cosmetic purposes; nutritional additives for medical purposes, not for pain relief or cosmetic purposes; medicinal tonics and substitutes therefor, namely, dietary supplements for humans and animals, not for pain relief or cosmetic purposes; calcium pharmaceutical preparations in the nature of calcium supplements, not for pain relief or cosmetic purposes; reagent paper for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; capsules sold empty for pharmaceuticals; mothproofing paper; lacteal flour for babies; dietary and nutritional supplements in tablet, chewable, powder, capsule, liquid or gel form, not for pain relief or cosmetic purposes; lactic acid bacteria-based food supplements in gel, tablet, chewable, powder, capsule or liquid form, not for pain relief or cosmetic purposes; dietary and nutritional supplements, not for pain relief or cosmetic purposes; dietetic pharmaceuticals, namely, dietetic foods and beverages adapted for medical or veterinary use; dietetic food adapted for medical purposes, namely, food for chewing and swallowing disorders; food thickener for dysphagia for medical purposes, namely, food additives in the nature of glucose and lecithin for medical purposes for assistance with swallowing; dietetic beverages adapted for medical purposes; dietetic food adapted for medical purposes; beverages for babies, namely, dietary supplement beverages for aiding sleep and promoting digestion for babies; food for babies; nutritional supplements for animal foodstuffs, not for pain relief or cosmetic purposes; dietary supplements for animals, not for pain relief or cosmetic purposes; semen for artificial insemination; cultures of microorganisms for medical or veterinary use

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 18, 2026 REM3
NEW REPRESENTATIVE AT IB RECEIVED
May 23, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 24, 2021 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Sep 1, 2021 XXSS
GENERIC MADRID TRANSACTION CREATED
Sep 1, 2021 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 18, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
May 18, 2021 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 27, 2021 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 10, 2021 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 10, 2021 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 2, 2021 NPUB
PUBLISHED FOR OPPOSITION
Mar 2, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Mar 1, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 10, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 10, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 10, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 21, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 11, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 10, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 10, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 11, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jun 11, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jun 11, 2020 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 18, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 18, 2020 CRFA
ASSIGNED TO LIE
May 11, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 6, 2020 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 6, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 6, 2020 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 6, 2020 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 6, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 6, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 6, 2020 COAR
REFUSAL PROCESSED BY IB
Nov 22, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 6, 2019 RFCS
REFUSAL PROCESSED BY MPU
Nov 6, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 22, 2019 RFCR
APPLICATION FILING RECEIPT MAILED
Oct 22, 2019 MAFR
NON-FINAL ACTION WRITTEN
Oct 21, 2019 CNRT
ASSIGNED TO EXAMINER
Oct 16, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 16, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 10, 2019 REPR